If you liked this article you might like

Shire Gains as it Seeks European Approval For Dry Eye Treatment

One of Wall Street's Hottest Biotech Stocks Tanks, Is Now the Time to Pounce?

Teva Shares Are Taking a Beating and Dragging Down the Generic Drugmakers

Pfizer Investors Keep Eyes on Pipeline as Viagra, Lyrica Approach Patent Cliff

These Stocks Are Ready to Reverse Course